Novel Attenuated Chikungunya Vaccine Candidates Elicit Protective Immunity in C57BL/6 mice

Chikungunya virus (CHIKV) is a reemerging mosquito-borne alphavirus that has caused severe epidemics in Africa and Asia and occasionally in Europe. As of today, there is no licensed vaccine available to prevent CHIKV infection. Here we describe the development and evaluation of novel CHIKV vaccine c...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Hallengärd, David, Kakoulidou, Maria, Lulla, Aleksei, Kümmerer, Beate M., Johansson, Daniel X., Mutso, Margit, Lulla, Valeria, Fazakerley, John K., Roques, Pierre, Le Grand, Roger, Merits, Andres, Liljeström, Peter
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology 2014
Aiheet:
Vaccines and Antiviral Agents
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3958085/
https://ncbi.nlm.nih.gov/pubmed/24371047
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.03453-13
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia